Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Rogues

<< Previous

Bullboard Posts

Next >>

Comment by 90guppyon Jul 26, 2020 6:05pm

50 Views

Post# 31321432

RE:Rogues

Its a classic ploy, measure out the emotions of retails. Thats what they do, fuds, shout loud, scream with anger and blame here, blame there, save the world. Hoping greenhorns will fall victim on their strategy. Just classic, no matter how tired and used up that strategy they will still do it hoping new and gullible retails will fall for it. Good luck with that, a lot have loaded when VXL was 0.08, 0.085, 0.09 and 0.095, especially 0.085.